dactinomycin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

dactinomycin has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maruyama, K; Morishita, E; Ohtake, S; Sekiya, A; Torishima, H1

Other Studies

1 other study(ies) available for dactinomycin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells.
    Journal of atherosclerosis and thrombosis, 2015, Jul-23, Volume: 22, Issue:7

    Topics: Anticoagulants; Antigens; Blotting, Western; Cells, Cultured; Chromones; Dactinomycin; Fatty Acids, Monounsaturated; Fluvastatin; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Lipoproteins; Luciferases; Maleimides; Mevalonic Acid; Morpholines; Pyridines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Up-Regulation

2015